MARIA VANADIA: Open Payments
NPI 1861247603 · NORTH PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 61 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,307 · 2025 $1,890
Food & beverage: $1,631Education: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $394 |
| Galderma Laboratories, L.P. | 8 | $241 |
| Incyte Corporation | 8 | $212 |
| Janssen Biotech, Inc. | 2 | $175 |
| Regeneron Healthcare Solutions, Inc. | 4 | $166 |
| GENZYME CORPORATION | 2 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Organon LLC | 3 | $82 |
| Amgen Inc. | 3 | $79 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, NEMLUVIO, TREMFYA, RINVOQ, Otezla, Sotyktu.
Industry payments across RI — which companies pay providers there.
